Basic Colcrys Information

• INN (International Nonproprietary Name): Colchicine (also known as colchicina in Italian/Spanish and colchicin in German/French).
• Brand Names Available In United States: Colcrys (0.6 mg purple film-coated tablet debossed “AR 374”), Gloperba (oral solution 0.6 mg/5 mL), Mitigare (capsule 0.6 mg), Lodoco (tablet used for cardiovascular risk in some regions).
• ATC Code: M04AC01 (Musculo-skeletal system; Antigout preparations; Preparations with no uric acid effect; Colchicine).
• Forms & Dosages: Tablets 0.6 mg (Colcrys, Lodoco); Capsules 0.6 mg (Mitigare); Oral Solution 0.6 mg/5 mL (Gloperba).
• Manufacturers In United States: URL Pharma (Colcrys) and multiple generics from companies such as Hikma and Prasco.
• Registration Status In United States: FDA approved since 1961 for gout treatment and Familial Mediterranean Fever (FMF).
• OTC / Rx Classification: Prescription only (Rx) in regulated markets.

Instructions, Warnings, And Daily-Life Integration

Worried about taking Colcrys safely at home and while traveling?

Read the prescription label and the patient leaflet every time before dosing Colcrys or any colchicine product.

Confirm which brand and form you were prescribed before taking a dose — Colcrys tablet, Mitigare capsule, or Gloperba oral solution.

Major warning: avoid colchicine in severe renal or hepatic impairment and do not combine it with strong CYP3A4 or P‑gp inhibitors if renal or hepatic dysfunction exists because of risk of fatal toxicity.

Store colchicine products at 20–25°C (68–77°F), keep them in their original packaging, and protect tablets and solution from moisture.

Do not freeze Gloperba oral solution.

Carry a small travel kit with your 0.6 mg tablets or a Gloperba bottle, a printed copy of dosing instructions, and an emergency contact for toxicity questions.

If you develop significant gastrointestinal upset while taking colchicine, slow down, sip water, and call your prescriber.

If you suspect overdose — severe vomiting, diarrhea, numbness, muscle weakness, or confusion — seek immediate medical care because colchicine toxicity can be life‑threatening.

Preferred quick items: a one-page emergency checklist and a wallet card listing medication name, form, and dose.

• Emergency Checklist: Stop the medication, call emergency services, bring medication bottle, note timing and amount taken.
• Wallet Card Template: Medication name (Colcrys/colchicine), dose (0.6 mg), formulation (tablet/capsule/solution), prescriber contact, pharmacy phone.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Does it matter whether colchicine is taken in the morning or evening?

For prophylaxis, 0.6 mg once or twice daily is the common regimen, so choose the time that fits your routine for best adherence.

Taking the dose in the morning works well for people who already take medications with breakfast and prefer consistent morning routines.

Taking colchicine in the evening may reduce daytime gastrointestinal disruption for those who experience mild nausea or loose stools with daytime dosing.

For acute gout, follow the single-dose strategy: 1.2 mg at onset, then 0.6 mg one hour later, not to exceed 1.8 mg in the first hour.

Alternatively for acute flare management, label regimens allow 0.6 mg every 12–24 hours until symptoms improve, within label limits.

Outside the United States, for some low‑dose cardiovascular indications Lodoco‑style dosing of 0.5 mg once daily is used; this is not a U.S. standard for cardiovascular prevention.

Checklist for dosing times: pick morning for routine, evening if GI symptoms are bothersome, and set an alarm or pillbox reminder to aid adherence.

• Pros: Morning dosing aids adherence and pairs with other meds.
• Cons: Daytime dosing can worsen GI symptoms for some people.

Taking With Or Without Meals

Will food help with colchicine side effects?

Taking colchicine with food or a light snack often reduces nausea and diarrhea, and it is a practical first step if mild GI upset occurs.

If using Gloperba oral solution, measure carefully — 0.6 mg per 5 mL — and consider taking it with a small amount of food to lessen gastric irritation.

If gastrointestinal side effects persist despite taking colchicine with food, speak with your prescriber about dose spacing or switching formulations between tablet, capsule, or solution.

Patients who prefer tablets often note ease of dosing with Colcrys 0.6 mg tablets, while those with swallowing difficulties may opt for Gloperba oral solution.

For acute flares, early dosing before symptoms peak gives better control because colchicine targets the inflammatory response rather than uric acid levels.

Practical checklist: confirm formulation, measure solution doses, pair with a light snack, and track side effects to report to the clinician.

Safety Priorities

Who Should Avoid It

Are there people who must not take colchicine at all?

Absolute contraindications include known hypersensitivity to colchicine and severe renal or hepatic impairment, especially when strong CYP3A4 or P‑gp inhibitors are present.

Colchicine is contraindicated in patients on dialysis or with very low glomerular filtration rate due to high risk of toxicity.

Exercise caution in elderly or frail patients and in those with significant gastrointestinal, cardiac, hematologic, or hepatic disease because adverse effects and drug accumulation are more likely.

For children, colchicine use is limited to Familial Mediterranean Fever (FMF) in patients aged four years and older under specialist guidance.

Discuss baseline labs and ongoing monitoring with your prescriber if you have renal or hepatic impairment before starting colchicine.

Activities To Limit

Which activities should be avoided while taking colchicine?

If dizziness, significant weakness, or severe gastrointestinal upset occurs, avoid driving or operating heavy machinery until symptoms resolve.

Muscle pain or signs of myopathy are rare but can impair physical activity and should prompt immediate reporting to the clinician.

During acute diarrhea or vomiting prioritize hydration and avoid intense exercise until stable.

Avoid self-medicating with over‑the‑counter drugs that can interact with colchicine — always check with the pharmacist first.

• Red Flags: Severe diarrhea, muscle weakness, unusual bleeding or bruising, fever — seek medical attention immediately.
• Immediate Actions: Stop colchicine if severe symptoms start, hydrate, and contact your prescriber or emergency services.

Dosage & Adjustments

General Regimen

What is the usual colchicine dosing for adults?

Standard adult dosing uses 0.6 mg tablets or capsules, or 0.6 mg/5 mL oral solution depending on formulation and patient needs.

For an acute gout flare, one regimen is 1.2 mg at onset then 0.6 mg one hour later, with a maximum of 1.8 mg in the first hour.

Alternative label regimens include 0.6 mg every 12 or 24 hours until symptoms resolve, staying within label limits.

For prophylaxis, 0.6 mg once daily or 0.6 mg twice daily are common approaches to reduce frequency of gout attacks.

For FMF in adults, typical total daily doses range from 1.2 to 2.4 mg per day in divided doses, tailored to response and tolerability.

Special Cases

How should doses change for kidney, liver, or age concerns?

Renal impairment requires dose reduction or avoidance in moderate to severe cases, and colchicine is contraindicated in dialysis or very low GFR situations.

In hepatic impairment, reduce the dose for moderate disease and avoid colchicine in severe active hepatic disease.

Elderly patients benefit from lower starting doses and closer monitoring due to higher toxicity risk.

When co-prescribing strong CYP3A4 or P‑gp inhibitors, reassess dosing or avoid the combination because interactions can rapidly raise colchicine concentrations.

For cardiovascular secondary prevention in some regions, lower fixed doses such as 0.5 mg once daily are used, though this varies outside the United States.

• Dosing Adjustment Checklist: Review renal function, check hepatic status, list interacting drugs, consider lower start doses for elderly.

User Testimonials

Positive Reports

Do patients notice a real difference with colchicine?

Many report rapid relief of gout pain within 24–48 hours when colchicine dosing is started early in a flare.

Patients on prophylactic colchicine, 0.6 mg once or twice daily, commonly report fewer recurrent attacks over time.

Some patients appreciate the small size and markings of the Colcrys 0.6 mg tablet (debossed “AR 374”), which is easy to swallow and identify.

Availability of Gloperba oral solution helps patients with swallowing issues maintain consistent dosing and adherence.

Low‑dose regimens used for cardiovascular prevention in other regions are often described by users as low pill burden and reassuring, although regional availability varies.

Common Challenges

What problems do patients mention most often?

Gastrointestinal upset — diarrhea, nausea, and abdominal pain — is the most frequent reason patients stop colchicine therapy.

Some patients get confused during acute flares about the timing of the initial 1.2 mg and the follow-up 0.6 mg dose.

Access and cost issues can be barriers, with brand versus generic confusion between Colcrys, Mitigare, and generic colchicine formulations.

• Pros: Fast relief, multiple formulations (tablet, capsule, solution), proven FMF indication.
• Cons: GI side effects, potential interactions, variable cost and availability.

Checklist for clinic conversations: review side effects, confirm formulation, and discuss cost-saving generic options if available.

Buying Guide

Pharmacy Sources

Where should colchicine be purchased?

Colchicine is prescription‑only in regulated markets, and patients should buy from licensed pharmacies, local or reputable online sellers that require a valid prescription.

In the United States, Colcrys (0.6 mg tablet), Mitigare (capsule), and Gloperba (oral solution) are brand examples, and generics are available from manufacturers such as Hikma and Prasco.

In European countries and Romania, verify brands via national registries and the ANMDMR public database for current approvals and suppliers.

In our online pharmacy, colcrys is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

How can patients save on cost?

Prices vary by brand, dose, insurance coverage, and pharmacy discounts; generics are often cheaper than brand products.

Compare retail price versus mail-order 90‑day supplies, and check manufacturer coupons or patient assistance programs to reduce out‑of‑pocket costs.

Verify bioequivalence when choosing generics and confirm packaging integrity and expiry dates when ordering online.

• Safe Online Purchase Checklist: Verify licensed pharmacy NPI, require a prescription, check packaging and expiration, confirm return policy.

What’s Inside & How It Works

Ingredients Overview

What is in Colcrys and similar products?

The active ingredient is colchicine (International Nonproprietary Name: colchicine).

Common marketed forms include tablets 0.6 mg (Colcrys, Lodoco), capsules 0.6 mg (Mitigare), and oral solution 0.6 mg/5 mL (Gloperba).

Excipients vary by manufacturer, so check the specific product leaflet for potential allergens or formulation differences.

Mechanism Basics

How does colchicine relieve gout pain without lowering uric acid?

Colchicine disrupts microtubule formation in neutrophils, reducing their migration and activation at inflamed joints.

This anti‑inflammatory action dampens the cellular inflammatory cascade responsible for gout pain, which is why early dosing during a flare is more effective.

Because colchicine does not lower uric acid, urate-lowering therapy such as allopurinol or febuxostat is needed for long‑term control of hyperuricemia.

• Patient Handout Flowchart: Acute flare → early colchicine dosing → reduced neutrophil activity → symptom improvement.

Main Indications

Approved Uses

What are the FDA‑approved uses of colchicine?

In the United States, colchicine has FDA approval for treatment of acute gout flares and for Familial Mediterranean Fever (FMF); it has marketed approvals since 1961 for these indications.

Standard dosing for acute gout includes the single 1.2 mg then 0.6 mg approach, or label regimens of 0.6 mg every 12–24 hours within approved limits.

For FMF, adult dosing typically ranges from 1.2 to 2.4 mg per day in divided doses, adjusted for response and tolerability.

Off-Label Uses

Are there other conditions colchicine is used for?

Clinicians sometimes prescribe colchicine off‑label for pericarditis and other inflammatory conditions, with evidence varying by indication and specialist guidance.

Off‑label use should involve a clear discussion of potential benefits and risks and follow specialist guidelines where available.

• Approved: Acute gout, FMF.
• Common Off‑Label: Pericarditis and selected inflammatory indications under specialist care.

Interaction Warnings

Food Interactions

Can food or drink change colchicine levels?

Grapefruit and grapefruit juice can inhibit CYP3A4 and may increase colchicine blood levels; avoid grapefruit while taking colchicine or discuss with your clinician.

Alcohol does not change colchicine metabolism significantly but may worsen GI side effects and increase dehydration risk during diarrhea, so limit alcohol when starting therapy.

Drug Conflicts

Which medications must not be mixed with colchicine?

Strong CYP3A4 inhibitors such as clarithromycin and ketoconazole, and strong P‑gp inhibitors, can dramatically raise colchicine concentrations and risk fatal toxicity, especially in renal or hepatic impairment.

Other interactions include certain macrolide antibiotics, HIV protease inhibitors, and calcineurin inhibitors; co‑use with statins requires monitoring for myopathy.

Always bring a complete list of prescription, over‑the‑counter medications, and supplements to the prescriber and pharmacist for a medication review.

• High‑Risk Interaction Checklist: Avoid strong CYP3A4/P‑gp inhibitors, check statin combinations, verify antibiotics before use.

Latest Evidence & Insights

Recent Trials

What does recent research say about colchicine?

Recent trials have examined low‑dose colchicine for secondary cardiovascular prevention and compared colchicine to other anti‑inflammatories in select populations.

Some studies report benefits in specific cardiovascular groups with low‑dose regimens, but adoption and guideline recommendations vary by region.

For gout, evidence supports early colchicine administration to reduce symptom severity during flares.

Practical Takeaways

How should patients translate evidence into care?

Keep current with FDA, EMA, and national guideline updates for new approvals or safety advisories affecting colchicine use.

For patients, the actionable points remain early colchicine for gout flares and low‑dose prophylaxis to prevent recurrent attacks when indicated.

Discuss new indications or regional cardiovascular uses with a specialist before changing therapy.

• Quick Checklist: Ask your clinician about new evidence, check label updates, and discuss specialist referral for off‑label cardiovascular uses.

Alternative Choices

Drug Alternatives

What can be used instead of colchicine for acute gout?

NSAIDs such as indomethacin or naproxen and oral corticosteroids are effective alternatives for acute gout, selected based on patient comorbidities like renal or cardiovascular risk.

For long‑term urate control, allopurinol or febuxostat lower uric acid but do not treat acute inflammation and so are used alongside acute therapies when indicated.

If a patient cannot tolerate colchicine or has contraindications, discuss these alternatives with the clinician to tailor safe treatment.

Non-Drug Options

Which lifestyle measures help with gout and FMF management?

Rest, elevation, cold packs, and temporary activity modification help during acute flares.

Long‑term measures include dietary changes (reduced alcohol and purine-rich foods), weight management, and adherence to urate‑lowering therapy when prescribed.

For FMF, specialist follow‑up and genetic counseling are important components of care.

• Patient Checklist: Use cold therapy during flares, adjust diet, maintain hydration, and follow up for urate control if recurrent attacks occur.

Regulation Snapshot

US Status

Is colchicine regulated in the United States?

Colchicine is FDA‑approved for gout treatment and Familial Mediterranean Fever and is marketed in various formulations including Colcrys 0.6 mg tablets (purple, debossed “AR 374”), Gloperba oral solution, Mitigare capsule, and Lodoco in some regions.

Colchicine is classified as prescription‑only (Rx) in regulated markets.

International Notes

How does availability differ outside the United States?

In the EU, Canada, and other countries colchicine and generics are licensed and marketed under local names and packaging; in Romania products must be registered with the ANMDMR public registry for local approval.

Regulatory guidance and labeling may vary by country, so always check national registries such as the FDA, EMA, or ANMDMR for current product information and safety advisories.

• Key Points: Check FDA/EMA/ANMDMR databases for current approvals and safety updates.

FAQ Section

Quick Answers

Can colchicine be bought over the counter?

No — colchicine is prescription‑only in regulated markets.

What if I miss a dose?

Take the missed dose as soon as remembered, but skip it if it is close to the next scheduled dose and do not double up.

Can children take colchicine?

Children may receive colchicine for FMF at ages four years and older under specialist guidance, but colchicine is not approved for pediatric gout.

When To Call A Doctor

Which problems require immediate contact with a clinician?

Call immediately for severe abdominal pain with vomiting or diarrhea, new muscle weakness, unexplained fever, bruising or bleeding, or other signs of infection, which can signal toxicity or bone marrow suppression.

For dosing confusion during a flare, contact your prescriber before repeating doses to avoid accidental overdose.

• When To Call Checklist: Severe GI symptoms, new muscle weakness, fever, bleeding, or confusion — seek urgent care.

Guidelines For Proper Use

Storage & Transport

How should colchicine be stored and transported?

Store colchicine at 20–25°C (68–77°F), with brief excursions permitted between 15–30°C.

Keep colchicine in its original packaging and protect it from moisture.

Do not freeze oral solutions such as Gloperba, and carry only small quantities when traveling while keeping a copy of prescription information.

Missed Dose & Overdose

What should be done for a missed dose or suspected overdose?

If you miss a dose, take it when remembered unless it is close to the next dose; do not double the dose to catch up.

Overdose is a medical emergency — early signs include severe GI symptoms, hypotension, multi‑organ dysfunction, and bone marrow suppression.

If overdose is suspected, seek emergency care immediately and bring the medication packaging and timing information to the emergency room.

• Emergency Steps: Stop colchicine, call emergency services, bring pill bottle and timing, hydrate if possible, inform clinicians about other medications.
• Wallet Card Template: Medication, dose, formulation, prescriber, pharmacy phone.

Delivery Across United States